Oxford Nanopore releases Short Fragment Mode
Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA
Today, Short Fragment Mode will be integrated into the operating software that drives nanopore devices, allowing sequencing of fragments as short as 20 bases on nanopore platforms.
Using nanopore technology, it's possible to sequence short to ultra-long fragments of DNA. Recent developments in software have enabled Oxford Nanopore to "unlock" the ability to sequence the shortest of DNA fragments, down to 20 bases in length.
Following the MinKNOW 22.03 software release today, all customers will instantly gain access to the first release of Short Fragment Mode (SFM) at no extra cost. As the update is a result of software rather than chemistry updates, users will not require any new sequencing reagents or devices to reap the benefits of SFM .
Nanopore technology is designed to enable a user to sequence whatever DNA fragment length they present to the pore. Having already demonstrated sequencing reads greater than four megabases in length, nanopore sequencing is the only technology on the market capable of sequencing DNA lengths spanning five orders of magnitude in a single technology. From the single-use Flongle to the high-throughput PromethION, SFM will be available at the scale required for users to answer their most crucial biological questions.
Short Fragment mode is also coupled with Oxford Nanopore's ability to generate high outputs per flow cell (with over 250M reads demonstrated on a single PromethION flow cell) of information rich data. Users can now easily access methylation information of short molecules, such as cell free DNA, using the latest methylation detection tool Remora.
This latest release enables users to generate highly accurate information rich data on any molecule from 20 bases to millions of bases long using nanopore technology. The team look forward to working with the Nanopore Community to show the capability of this method to uncover new areas of biology.
-end-
Short Fragment Mode applications: https://nanoporetech.com/applications/short-fragment-mode
Contact: media@nanoporetech.com
Forward-looking statements
This announcement contains certain forward-looking statements. Phrases such as "potential", "expect", "intend", "anticipate", "when validated", and similar expressions of a future or forward-looking nature should also be considered forward-looking statements. Forward-looking statements address our expected future business, and by definition address matters that are, to different degrees, uncertain and may involve factors beyond our control.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 hours ago ASOS
- 5 hours ago MJ Gleeson
- 5 hours ago Rolls-Royce Holdings
- 5 hours ago Crest Nicholson Holdings
- 6 hours ago Naked Wines